The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Actavis PLC

NYSE: ACT
Last

(U.S.) $279.12

Today's change+1.11 +0.40%
Updated January 23 4:05 PM EST. Delayed by at least 15 minutes.
 

Actavis PLC

NYSE: ACT
Last

(U.S.) $279.12

Today's change+1.11 +0.40%
Updated January 23 4:05 PM EST. Delayed by at least 15 minutes.

Actavis PLC Hits New 52-week High

Actavis PLC closed up Friday by (U.S.)$1.11 or 0.40% to (U.S.)$279.12 and setting a new 52-week high. Over the last five days, shares have gained 3.89% and outperformed the S&P 500 index over the last 52 weeks with a 57.53% increase in price.

Key company metrics

  • Open(U.S.) $277.65
  • Previous close(U.S.) $278.01
  • High(U.S.) $280.24
  • Low(U.S.) $276.81
  • Bid / Ask-- / --
  • YTD % change+8.43%
  • Volume2,716,568
  • Average volume (10-day)2,664,660
  • Average volume (1-month)2,421,051
  • Average volume (3-month)3,003,017
  • 52-week range(U.S.) $174.94 to (U.S.) $280.24
  • Beta0.28
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward20.46×
  • Forward PEG0.92×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$4.18
Updated January 23 4:05 PM EST. Delayed by at least 15 minutes.
S&P TSX0.10%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue3,6832,6672,5972,720
Total other revenue----5859
Total revenue3,6832,6672,6552,779
Gross profit1,8001,3711,3041,249
Total cost of revenue1,8831,2971,2931,472
Total operating expense4,7052,4822,4472,854
Selling / general / administrative1,275527547545
Research & development697158172190
Depreciation / amortization874423424388
Interest expense (income), net operating--------
Unusual expense (income)-237812259
Other operating expenses, total--------
Operating income-1,022185208-75
Interest income (expense), net non-operating-132-79-73-71
Gain (loss) on sale of assets--------
Other--------
Income before tax-1,15192141-147
Income after tax-1,0434997-149
Income tax, total-10844442
Net income-1,0434997-148
Total adjustments to net income--------
Net income before extra. items-1,0434997-148
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-1,0434997-148
Inc. avail. to common incl. extra. items-1,0434997-148
Diluted net income-1,0434997-148
Dilution adjustment0000
Diluted weighted average shares264175175174
Diluted EPS excluding extraordinary itemsvalue per share-3.950.280.55-0.85
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-4.000.511.221.69